Carillo, Gabriel C.
HRN: 21-87-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/05/2022
REMDESIVIR 100MG (VIAL)
09/05/2022
09/09/2022
IV
200mg LD Then 100mg
Once A Day
COVID-19 Infection RAgT Confirmed-severe
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes